A Phase 1 Bioequivalence Study of Efgartigimod PH20 SC Administered Via a Prefilled Syringe Versus a Vial+Syringe Presentation in Healthy Adults
Clinical trial NCT05817435 · COMPLETED
Trial details
- NCT number
- NCT05817435
- Sponsor
- argenx
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2023-05-12
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.